Drug firm Dr Reddy's Laboratories today said the US health regulator has lifted an import alert issued on its Mexico-based subsidiary, paving way for the company to export products from the facility to the US market.
"The import alert at Quimicas Falcon de Mexico SA de C V (Dr Reddy's chemical manufacturing facility at Cuernavaca, Mexico), a wholly owned subsidiary of Dr Reddy's Laboratories has been lifted," the drug firm said in a statement.
The company received a clearance from the US Food and Drug Administration (USFDA) on July 26, 2012, it added.
"With the satisfactory closure of observations in the warning letter and the lifting of the import alert, Dr Reddy's can now start importing products to the US from this facility," the company said.
Hyderabad-based firm's Mexico facility was inspected by USFDA in November 2010.
Based on observations by the USFDA, a warning letter was issued to the company on June 14, 2011, the company said, adding that the company worked with health regulator to resolve the observations in the warning letter.
"An inspection report after the last inspection from March 26-30, 2012 indicated that they are satisfied with all the outstanding action points that Dr Reddy's has submitted," it added.
The Mexico facility produces intermediates and active pharmaceutical ingredients.
Shares of Dr Reddy's Laboratories today closed at Rs 1,621.10 apiece on the BSE, down 0.10% from its previous close.